Early Vascular Ageing in the YOUth
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Cardiovascular Risk Factor
- Atherosclerosis
- Vascular Diseases
- Cardiovascular Diseases
- Cardiovascular Pathology
- Headache
- Hypertension
- Life Style
- Vascular Stiffness
- Sleep Disorder
- Non Alcoholic Fatty Liver Disease
- Obesity
- Overweight
- Sleep
- Type
- Observational
- Design
- Observational Model: CohortTime Perspective: Cross-Sectional
Participation Requirements
- Age
- Between 14 years and 19 years
- Gender
- Both males and females
Description
EVA4YOU is a cross-sectional study enrolling 3000 students and apprentices aged between 14 and 19 years. Examinations are conducted at schools and companies throughout Tyrol, Austria and include laboratory measurements; standardized medical interviews; anthropometry; liver elastography; ultrasonogra...
EVA4YOU is a cross-sectional study enrolling 3000 students and apprentices aged between 14 and 19 years. Examinations are conducted at schools and companies throughout Tyrol, Austria and include laboratory measurements; standardized medical interviews; anthropometry; liver elastography; ultrasonography of the carotid artery and the aorta, and blood pressure, bioelectrical impedance; visceral abdominal fat-tissue-thickness measurement, pulse-wave velocity measurements. The study hypothesis is that the cardiovascular risk factors measured already influence the formation of atherosclerosis (measured as carotid and aortic Intima-Media Thickness and Pulse-Wave-Velocity) in adolescents. A long-term follow-up by means of record linkage is furthermore planned to evaluate the effect of early atherosclerosis and the cardiovascular risk profile on future morbidity with a special focus cardio- and cerebrovascular events.
Tracking Information
- NCT #
- NCT04598685
- Collaborators
- Medical University Innsbruck
- Tirol Kiniken GmbH
- Evaluation Software Development (ESD)
- Austrian Research Promotion Agency (FFG)
- Investigators
- Principal Investigator: Michael Knoflach, MD Medical University Innsbruck
Get Well Soon